Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (301-310 of 328) with videos related to

Pageof 33
Sort By:
Frontiers in Cardiovascular Medicine|May 1, 2026
Ionizing radiation expands a p90RSK-activated patrolling monocyte subset: modulation by colchicineMasaki Imanishi, Venkata S K Samanthapudi, Nhat-Tu Le, et al.
Journal of Hepatocellular Carcinoma|March 10, 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with RadiotherapyBrian De, Sweet Ping Ng, Amy Y Liu, et al.
Frontiers in Cardiovascular Medicine|November 25, 2022
Radiation therapy induces immunosenescence mediated by p90RSKMasaki Imanishi, Haizi Cheng, Sivareddy Kotla, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 24, 2025
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case ReportBingnan Zhang, Komal B Shah, Mitchell Parma, et al.
Journal of Cancer|September 14, 2020
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective StudyQi-Wen Li, Bo Qiu, Wen-Hua Liang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using <sup>18</sup>F-FDG PET/CT and DW-MRI: A Prospective Multicenter StudyAlicia S Borggreve, Lucas Goense, Peter S N van Rossum, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2026
Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trialTingshi Su, Ting Xu, Mei Chen, et al.
Frontiers in Cardiovascular Medicine|September 15, 2023
Endothelial activation and fibrotic changes are impeded by laminar flow-induced CHK1-SENP2 activity through mechanisms distinct from endothelial-to-mesenchymal cell transitionMinh T H Nguyen, Masaki Imanishi, Shengyu Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal CancerSteven H Lin, Brian P Hobbs, Vivek Verma, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Pageof 33

Showing results (301-310 of 328) with videos related to

Sort By:
Pageof 33
Frontiers in Cardiovascular Medicine|May 1, 2026
Ionizing radiation expands a p90RSK-activated patrolling monocyte subset: modulation by colchicineMasaki Imanishi, Venkata S K Samanthapudi, Nhat-Tu Le, et al.
Journal of Hepatocellular Carcinoma|March 10, 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with RadiotherapyBrian De, Sweet Ping Ng, Amy Y Liu, et al.
Frontiers in Cardiovascular Medicine|November 25, 2022
Radiation therapy induces immunosenescence mediated by p90RSKMasaki Imanishi, Haizi Cheng, Sivareddy Kotla, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 24, 2025
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case ReportBingnan Zhang, Komal B Shah, Mitchell Parma, et al.
Journal of Cancer|September 14, 2020
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective StudyQi-Wen Li, Bo Qiu, Wen-Hua Liang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using <sup>18</sup>F-FDG PET/CT and DW-MRI: A Prospective Multicenter StudyAlicia S Borggreve, Lucas Goense, Peter S N van Rossum, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2026
Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trialTingshi Su, Ting Xu, Mei Chen, et al.
Frontiers in Cardiovascular Medicine|September 15, 2023
Endothelial activation and fibrotic changes are impeded by laminar flow-induced CHK1-SENP2 activity through mechanisms distinct from endothelial-to-mesenchymal cell transitionMinh T H Nguyen, Masaki Imanishi, Shengyu Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal CancerSteven H Lin, Brian P Hobbs, Vivek Verma, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Pageof 33